CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 79 (6) , 1039-1046
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJournal of Clinical Oncology, 2011
- CADM1 Interacts with Tiam1 and Promotes Invasive Phenotype of Human T-cell Leukemia Virus Type I-transformed Cells and Adult T-cell Leukemia CellsJournal of Biological Chemistry, 2010
- T-cell receptor γ gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysisBritish Journal of Dermatology, 2009
- Adult T-cell leukaemia/lymphomaJournal of Clinical Pathology, 2007
- Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides–type cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 2007
- Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesisCancer Science, 2005
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemiaBlood, 2004
- Low CD7 Expression in Benign and Malignant Cutaneous Lymphocytic InfiltratesThe American Journal of Dermatopathology, 2002
- How Useful Are T-Cell Receptor Gene Rearrangement Studies as an Adjunct to the Histopathologic Diagnosis of Mycosis Fungoides?The American Journal of Dermatopathology, 1999